The Vienna CATScore for predicting cancer-associated venous thromboembolism: an external validation across multiple time points
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Society for thrombosis and hemostasis research
- Christian Doppler Research Association
- Österreichische Nationalstiftung für Forschung, Technologie und Entwicklung
- Bundesministerium für Digitalisierung und Wirtschaftsstandort
- Medizinische Universität Wien
- Roche
This publication has 42 references indexed in Scilit:
- Risk-Directed Ambulatory Thromboprophylaxis in Lung and Gastrointestinal CancersJAMA Oncology, 2023
- Utility of the Khorana and the new-Vienna CATS prediction scores in cancer patients of the HYPERCAN cohortJournal of Thrombosis and Haemostasis, 2023
- Venous thromboembolism in cancer patients: ESMO Clinical Practice GuidelineAnnals of Oncology, 2023
- Incidence of venous thromboembolism and discriminating capacity of Khorana score in lung cancer patients treated with immune checkpoint inhibitorsJournal of Thrombosis and Thrombolysis, 2022
- Thromboembolism in Patients with Metastatic Renal Cell Carcinoma Treated with ImmunotherapyTargeted Oncology, 2021
- Poorer baseline performance status is associated with increased thromboembolism risk in metastatic cancer patients treated with immunotherapySupportive Care in Cancer, 2021
- D-Dimer Enhances Risk-Targeted Thromboprophylaxis in Ambulatory Patients with CancerThe Oncologist, 2020
- Haemostatic biomarkers for prognosis and prediction of therapy response in patients with metastatic colorectal cancerThrombosis Research, 2020
- Long-term performance of risk scores for venous thromboembolism in ambulatory cancer patientsJournal of Thrombosis and Thrombolysis, 2019
- Incidence of Venous Thromboembolism and Its Effect on Survival Among Patients With Common CancersArchives of internal medicine (1960), 2006